ProKidney Corp.
PROK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -1.8% | -3.9% | 202.6% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -544.2% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -15,614.3% | -15,679.2% | -15,548.3% | -59,480.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7,589.4% | -7,489.6% | -7,275.7% | -27,997.4% |
| EPS Diluted | -0.12 | -0.13 | -0.13 | -0.17 |
| % Growth | 7.7% | 0% | 23.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |